Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RadiaCream is a topical emollient moisturizing cream developed by Medline, specifically formulated for patients undergoing radiotherapy. It is designed to restore and protect skin exposed to radiation and other harmful radiations by softening and moisturizing the skin. The product helps manage dry, itchy skin and minor irritations, functioning primarily through physical moisturization and the reinforcement of the skin's natural barrier rather than through a specific biological molecular target. It is intended for external use to alleviate radiation-induced skin changes and maintain skin integrity during cancer treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RadiaCream.